drugset / Trial / NCT02676765

Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy

NCT02676765

Phase 3 Terminated 58 enrolled Virginia Commonwealth University
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to determine if sublingual allergen immunotherapy tablets work by inducing a state of desensitization in mast cells and basophils.

Timeline

Start
2016-06
Primary completion
2018-01-18
Completion
2018-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject SCH 39641 Unknown 1 unknown Other
Subject SCH 697243 Other / unclassified 1 unknown Other

Indications

No indication recorded.